FIELD: organic synthesis. SUBSTANCE: quinoline derivatives with general formula 1: (1) are provided where R1 is hydrogen, C1-6-alkyl or NR4R5 group in which R4 and R5 are hydrogen, C1-6-alkyl, phenyl or pyridyl, naphthyl, 5- or 6- membered heterocyclic group including 1-2 endonuclear nitrogen, oxygen or sulfur atoms optionally substituted by alkyl, alkoxy, halogen, hydroxy, haloalkyl, or phenyl; Z is oxygen atom, carbonyl, or methylene; E sulfur or oxygen atom; m, p, and q = 0-4. Compound possess hypoglycemic activity. EFFECT: extended choice of hypoglycemic drugs. 3 cl, 2 tbl, 28 ex
Title | Year | Author | Number |
---|---|---|---|
URAT1 INHIBITORS | 2015 |
|
RU2721844C2 |
NOVEL PYRROLE DERIVATIVE HAVING AS SUBSTITUTES UREIDE GROUP, AMINOCARBONYL GROUP AND BICYCLIC GROUP, OPTIONALLY SUBSTITUTED | 2009 |
|
RU2500669C2 |
HYBRID DERIVATIVES OF (1H-1,2,4) TRIAZOLE AND SULPHUR-CONTAINING HETEROCYCLES: DERIVATIVES OF THIAZOLIDINE-2,4-DIONE, THIOMORPHOLINE-3-ONE, AND 1,4-THIAZEPAN-3-ONE, EXHIBITING ANTIMICROBIAL ACTIVITY | 2020 |
|
RU2771027C1 |
ACTIVATING AGENT FOR RECEPTOR ACTIVATED BY PEROXISOME GROWTH-STIMULATING AGENTS | 2009 |
|
RU2501794C2 |
MORPHINAN DERIVATIVE | 2016 |
|
RU2762567C2 |
THIOPHENE DERIVATIVE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2172737C2 |
HYBRID AMIDES BASED ON TRIAZOLE AND THIAZOLIDINE HAVING ANTIMICROBIAL ACTIVITY | 2018 |
|
RU2703997C1 |
SUBSTITUTED QUINOLINE COMPOUNDS AND METHODS OF THEIR APPLICATION | 2012 |
|
RU2568258C2 |
HETEROBICYCLIC DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2170737C2 |
ARYLSULFONYLMETHYL OR ARYLSULFONAMIDE DERIVATIVES OF AROMATICS, PHARMACEUTICAL COMPOSITION BASED ON THEM AND WAY OF TREATMENT AGAINST ABNORMALITIES RESPONSIVE TO DOPAMINE D RECEPTOR LIGAND TREATMENT, WITH THEIR HELP | 2005 |
|
RU2442781C2 |
Authors
Dates
1999-09-20—Published
1995-10-20—Filed